QAV680

DRUG3 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

AsthmaSeasonal Allergic Rhinitis

Phase 2

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

CompletedNCT00784732

NovartisSeasonal Allergic Rhinitis

Start: 2008-09-30End: 2008-12-31Updated: 2016-11-18

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

CompletedNCT00814216

Start: 2008-12-31Updated: 2017-03-08

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

TerminatedNCT01103037

Novartis PharmaceuticalsAsthma

Start: 2010-03-31End: 2010-09-30Updated: 2020-12-19